These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1127 related articles for article (PubMed ID: 21813474)

  • 21. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
    Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
    J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Nan YM; Han F; Kong LB; Zhao SX; Wang RQ; Wu WJ; Yu J
    Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.
    Ye D; Yang K; Zang S; Lin Z; Chau HT; Wang Y; Zhang J; Shi J; Xu A; Lin S; Wang Y
    J Hepatol; 2016 Nov; 65(5):988-997. PubMed ID: 27266617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.
    Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D
    Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice.
    Fourcot A; Couchie D; Chobert MN; Zafrani ES; Mavier P; Laperche Y; Brouillet A
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1043-53. PubMed ID: 21350191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
    Queck A; Bode H; Uschner FE; Brol MJ; Graf C; Schulz M; Jansen C; Praktiknjo M; Schierwagen R; Klein S; Trautwein C; Wasmuth HE; Berres ML; Trebicka J; Lehmann J
    Front Immunol; 2020; 11():354. PubMed ID: 32218781
    [No Abstract]   [Full Text] [Related]  

  • 30. Curcumin protects against liver fibrosis by attenuating infiltration of Gr1hi monocytes through inhibition of monocyte chemoattractant protein-1.
    Huang R; Liu Y; Xiong Y; Wu H; Wang G; Sun Z; Chen J; Yan X; Pan Z; Xia J; Zhang Z; Wang J; Wu C
    Discov Med; 2016 Jun; 21(118):447-57. PubMed ID: 27448781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
    J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury.
    Mossanen JC; Krenkel O; Ergen C; Govaere O; Liepelt A; Puengel T; Heymann F; Kalthoff S; Lefebvre E; Eulberg D; Luedde T; Marx G; Strassburg CP; Roskams T; Trautwein C; Tacke F
    Hepatology; 2016 Nov; 64(5):1667-1682. PubMed ID: 27302828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity.
    Yang M; Kimchi ET; Staveley-O'Carroll KF; Li G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin reduces Ly6C
    Zhao XA; Chen G; Liu Y; Chen Y; Wu H; Xiong Y; Wang G; Jia B; Li Y; Xia J; Wang J; Yan X; Zhang Z; Huang R; Wu C
    Biomed Pharmacother; 2018 Oct; 106():868-878. PubMed ID: 30119257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
    Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
    J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis.
    Zaldivar MM; Pauels K; von Hundelshausen P; Berres ML; Schmitz P; Bornemann J; Kowalska MA; Gassler N; Streetz KL; Weiskirchen R; Trautwein C; Weber C; Wasmuth HE
    Hepatology; 2010 Apr; 51(4):1345-53. PubMed ID: 20162727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
    Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
    Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice.
    Kulkarni O; Pawar RD; Purschke W; Eulberg D; Selve N; Buchner K; Ninichuk V; Segerer S; Vielhauer V; Klussmann S; Anders HJ
    J Am Soc Nephrol; 2007 Aug; 18(8):2350-8. PubMed ID: 17625118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.